BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2018 2:33:54 AM | Browse: 974 | Download: 1755
 |
Received |
|
2018-06-07 00:39 |
 |
Peer-Review Started |
|
2018-06-07 08:57 |
 |
To Make the First Decision |
|
2018-06-21 01:06 |
 |
Return for Revision |
|
2018-06-29 12:26 |
 |
Revised |
|
2018-07-17 00:36 |
 |
Second Decision |
|
2018-07-31 12:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2018-08-01 04:27 |
 |
Articles in Press |
|
2018-08-01 04:27 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2018-08-13 22:54 |
 |
Typeset the Manuscript |
|
2018-09-17 01:10 |
 |
Publish the Manuscript Online |
|
2018-09-20 02:33 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Case Report |
Article Title |
Infant cholestasis patient with a novel missense mutation in the AKR1D1 gene successfully treated by early adequate supplementation with chenodeoxycholic acid: A case report and review of the literature
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hui-Hui Wang, Fei-Qiu Wen, Dong-Ling Dai, Jian-She Wang, Jing Zhao, Kenneth DR Setchell, Lina Shi, Shao-Ming Zhou, Si-Xi Liu and Qing-Hua Yang |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Guangdong medical research project |
A2018550 |
|
Corresponding Author |
Dong-Ling Dai, MD, PhD, Chief Doctor, Gastroenterology department, Shenzhen Children's Hospital, 7019 Yitian Road Futian District, Shenzhen 518036, Guangdong Province, China. daidong3529@sina.com |
Key Words |
Aldo-keto reductase family 1 member D1; Cholestasis; Congenital bile acid synthesis defect; Gene mutation |
Core Tip |
We report a case of an infant with primary 3-oxo-Δ4-steroid 5β-reductase deficiency with a novel missense mutation in the aldo-keto reductase family 1 member D1 (AKR1D1) gene. The patient was successfully treated by early adequate supplementation with chenodeoxycholic acid (CDCA). This case suggests that a novel compound heterozygous R307C mutation and loss of heterozygosity in the AKR1D1 gene play a pathogenic role in congenital bile acid synthesis defect type 2. Accurate diagnosis of the disease and early adequate supplementation with CDCA are vital for the amelioration of symptoms in clinical practice. |
Publish Date |
2018-09-20 02:33 |
Citation |
Wang HH, Wen FQ, Dai DL, Wang JS, Zhao J, Setchell KD, Shi LN, Zhou SM, Liu SX, Yang QH. Infant cholestasis patient with a novel missense mutation in the AKR1D1 gene successfully treated by early adequate supplementation with chenodeoxycholic acid: A case report and review of the literature. World J Gastroenterol 2018; 24(35): 4086-4092 |
URL |
http://www.wjgnet.com/1007-9327/full/v24/i35/4086.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v24.i35.4086 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345